Find Product:

Recombinant Malaria Antigen Pan [His]
DAGA-3016
Creative Diagnostics 1mg
Recombinant other Malaria Pf. MSP1 Protein, His, E.coli-100ug
QP12631-100ug
EnQuireBio 100ug
Recombinant other Malaria Pf. MSP1 Protein, His, E.coli-1mg
QP12631-1mg
EnQuireBio 1mg
Recombinant other Malaria Pf. MSP1 Protein, His, E.coli-500ug
QP12631-500ug
EnQuireBio 500ug
NATtrol Zika Virus Stock (Qualitative) (1 mL)
TEST
Zeptometrix 1 mL
Description: Please contact Gentaur in order to receive the datasheet of the product.
Native Feline Infectious Peritonitis Virus antigen
DAGA-3038
Creative Diagnostics 1mg
CA199 (Cancer antigen) ELISA test
13
Biobase 96T/Box
Description: ELISA based test for quantitative detection of CA199 (Cancer antigen)
CA153 (Cancer antigen) ELISA test
12
Biobase 96T/Box
Description: ELISA based test for quantitative detection of CA153 (Cancer antigen)
CA125 (Cancer antigen) ELISA test
11
Biobase 96T/Box
Description: ELISA based test for quantitative detection of CA125 (Cancer antigen)
CA50 (Cancer antigen) ELISA test
10
Biobase 96T/Box
Description: ELISA based test for quantitative detection of CA50 (Cancer antigen)
CEA (Cancer antigen) ELISA test
9
Biobase 96T/Box
Description: ELISA based test for quantitative detection of CEA (Cancer antigen)
NOVATest Antigen Rapid Test Kit (For Single Use) (NOVA Test)
nCov-500-01
Atlas Link Technology 1T
PSA (Prostate-specific antigen) ELISA test
8
Biobase 96T/Box
Description: ELISA based test for quantitative detection of PSA (Prostate-specific antigen)
NOVATest Antigen Rapid Kit (NOVA Test)
nCov-500
Atlas Link Technology 20 Tests
Inactivated Zika Virus Antigen (H/PF/2013)
VAng-Lsx0575-inquire
Creative Biolabs inquire
Description: Zika virus H/PF/2013, native antigen.
Malaria LDH antibody
10-1727
Fitzgerald 250 ug
Description: Mouse monoclonal Malaria LDH Pf/Pv antibody
Malaria HRP2 antibody
10-2251
Fitzgerald 1 mg
Description: Mouse monoclonal Malaria HRP2 antibody
Malaria HRP2 antibody
10-2252
Fitzgerald 1 mg
Description: Mouse monoclonal Malaria HRP2 antibody
Malaria pLDH antibody
10-2694
Fitzgerald 1 mg
Description: Mouse Monoclonal Malaria pLDH antibody
Malaria pLDH antibody
10-2695
Fitzgerald 1 mg
Description: Mouse Monoclonal Malaria pLDH antibody
Malaria pLDH antibody
10-2696
Fitzgerald 1 mg
Description: Mouse Monoclonal Malaria pLDH antibody
Malaria HRP2 protein
30-1804
Fitzgerald 200 ug
Description: Purified recombinant Malaria HRP2 protein
Malaria pLDH Antibody
abx022050-1mg
Abbexa 1 mg
Malaria HSP Protein
20-abx260294
Abbexa
  • 0.5 mg
  • 100 ug
  • 1 mg
Malaria ELISA Kit
DEIA1929
Creative Diagnostics 192T
Description: The Malaria ELISA Kit is intended for measurement of antibodies against Plasmodium in human serum or plasma (citrate).
HEV-Ag hepatitis E antigen ELISA test
94
Biobase 96T/Box
Description: ELISA based test for quantitative detection of HEV-Ag hepatitis E antigen
SARS-CoV-2 Rapid Antigen Test Nasal
9901-NCOV-03G
Roche Diagnostics 25 Tests/Kit
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke
HBeAg hepatitis B E antigen ELISA test
79
Biobase 96T/Box
Description: ELISA based test for quantitative detection of HBeAg hepatitis B E antigen
SARS-CoV-2 Antigen Rapid Test Kit
CoV2Ag-1
UnScience 1T
Description: This kit adopts the sandwich method and the technical principle of colloidal gold immunochromatography to qualitative determine the SARS-CoV-2 antigen. During the test, the sample is dropped into the sample well, and chromatography is performed under the capillary effect. The SARS-CoV-2 antigen in the sample combined with the colloidal goldlabeled SARS-CoV-2 monoclonal antibody I, and then spread to the test area. It is captured by another coated antibody (SARS-CoV-2 monoclonal antibody II), to form a complex and gather in the test area (T line). The quality control area is coated with the goat antimouse antibody, and the colloidal gold-labeled antibody is captured to form a complex and aggregate in the quality control area (C line). If the C line does not show color, it indicates that the result is invalid, and this sample needs to be tested again.
SARS-CoV-2 Antigen Rapid Test Kit
CoV2Ag-25
UnScience 25T/kit
Description: This product is used for in vitro qualitative detection of SARS-CoV-2 antigen in human oropharyngeal swabs, nasal swabs and nasopharyngeal swabs. It is helpful as an aid in the screening of early mild, asymptomatic, or acute patients for identification of SARS-CoV-2 infection.
ProPette LiquiLOCK Premium Pipette filter, 0.8um, pack of 5
P6080-PF
MTC Bio 5/pack
Description: ProPette LiquiLOCK Premium Pipette filter 0.8um
Recombinant Malaria Protein HSP70
7-07087
CHI Scientific 100µg
Recombinant Malaria Protein HSP70
7-07088
CHI Scientific 500µg
Recombinant Malaria Protein HSP70
7-07089
CHI Scientific 1000µg
Recombinant Malaria Cs Mosaic
7-07090
CHI Scientific 100µg
Recombinant Malaria Cs Mosaic
7-07091
CHI Scientific 500µg
Recombinant Malaria Cs Mosaic
7-07092
CHI Scientific 1000µg
Malaria LDH pan antibody
10-1464
Fitzgerald 500 ug
Description: Mouse monoclonal Malaria LDH (pan) antibody
Malaria pan pLDH antibody
10-2697
Fitzgerald 1 mg
Description: Mouse Monoclonal Malaria pan pLDH antibody
Malaria Cs Mosaic Protein
20-abx260295
Abbexa
  • 0.5 mg
  • 100 ug
  • 1 mg
Malaria pLDH pv protein
80-1535
Fitzgerald 1 mg
Description: Purified recombinant Plasmodium vivax pLDH protein (His tag)
Human Streptococcus Pneumoniae (SP) Antigen Rapid Test Kit
abx092096-20tests
Abbexa 20 tests
Rat PF-4(Platelet Factor-4) ELISA Kit
ER0243
FN Test 96T
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Rattus;Sensitivity: 0.469 ng/ml
PF-03814735
A4128-10
ApexBio 10 mg
Description: PF-03814735 is a potent, orally bioavailable, reversible inhibitor of both Aurora1 and Aurora2 kinases with IC50 values of 0.8nM and 5nM, respectively [1].PF-03814735 is an ATP competitive inhibitor of Aurora kinases.
PF-03814735
A4128-5
ApexBio 5 mg
Description: PF-03814735 is a potent, orally bioavailable, reversible inhibitor of both Aurora1 and Aurora2 kinases with IC50 values of 0.8nM and 5nM, respectively [1].PF-03814735 is an ATP competitive inhibitor of Aurora kinases.
PF-03814735
A4128-50
ApexBio 50 mg
Description: PF-03814735 is a potent, orally bioavailable, reversible inhibitor of both Aurora1 and Aurora2 kinases with IC50 values of 0.8nM and 5nM, respectively [1].PF-03814735 is an ATP competitive inhibitor of Aurora kinases.
PF-4981517
A4311-10
ApexBio 10 mg
Description: PF-4981517, also named CYP3cide, is a potent, efficient, and specific time-dependent inactivator of human CYP3A4. PF-4981517 is a very useful tool for understanding the relative roles of CYP3A4 versus CYP3A5 and the impact of CYP3A5 genetic polymorphism on a compound's pharmacokinetics.
PF-4981517
A4311-25
ApexBio 25 mg
Description: PF-4981517, also named CYP3cide, is a potent, efficient, and specific time-dependent inactivator of human CYP3A4. PF-4981517 is a very useful tool for understanding the relative roles of CYP3A4 versus CYP3A5 and the impact of CYP3A5 genetic polymorphism on a compound's pharmacokinetics.
PF-4981517
A4311-5
ApexBio 5 mg
Description: PF-4981517, also named CYP3cide, is a potent, efficient, and specific time-dependent inactivator of human CYP3A4. PF-4981517 is a very useful tool for understanding the relative roles of CYP3A4 versus CYP3A5 and the impact of CYP3A5 genetic polymorphism on a compound's pharmacokinetics.
PF-4981517
A4311-50
ApexBio 50 mg
Description: PF-4981517, also named CYP3cide, is a potent, efficient, and specific time-dependent inactivator of human CYP3A4. PF-4981517 is a very useful tool for understanding the relative roles of CYP3A4 versus CYP3A5 and the impact of CYP3A5 genetic polymorphism on a compound's pharmacokinetics.
PF-2545920
A4325-10
ApexBio 10 mg
Description: PF-2545920 is an inhibitor of phosphodiesterase 10A (PDE10A) with IC50 value of 0.37nM [1].PDE10A is highly expressed in the medium spiny neurons of the striatum and regulates both cGMP and cAMP.
PF-2545920
A4325-200
ApexBio 200 mg
Description: PF-2545920 is an inhibitor of phosphodiesterase 10A (PDE10A) with IC50 value of 0.37nM [1].PDE10A is highly expressed in the medium spiny neurons of the striatum and regulates both cGMP and cAMP.
PF-2545920
A4325-5
ApexBio 5 mg
Description: PF-2545920 is an inhibitor of phosphodiesterase 10A (PDE10A) with IC50 value of 0.37nM [1].PDE10A is highly expressed in the medium spiny neurons of the striatum and regulates both cGMP and cAMP.
PF-2545920
A4325-5.1
ApexBio 10 mM (in 1mL DMSO)
Description: PF-2545920 is an inhibitor of phosphodiesterase 10A (PDE10A) with IC50 value of 0.37nM [1].PDE10A is highly expressed in the medium spiny neurons of the striatum and regulates both cGMP and cAMP.
PF-2545920
A4325-50
ApexBio 50 mg
Description: PF-2545920 is an inhibitor of phosphodiesterase 10A (PDE10A) with IC50 value of 0.37nM [1].PDE10A is highly expressed in the medium spiny neurons of the striatum and regulates both cGMP and cAMP.
PF-3845
A4374-10
ApexBio 10 mg
Description: PF-3845 is a highly potent and selective inhibitor of fatty acid amide hydrolase (FAAH) with Ki value of 0.23?M [1].PF-3845 is a biaryl ether piperidine.
PF-3845
A4374-100
ApexBio 100 mg
Description: PF-3845 is a highly potent and selective inhibitor of fatty acid amide hydrolase (FAAH) with Ki value of 0.23?M [1].PF-3845 is a biaryl ether piperidine.
PF-3845
A4374-5
ApexBio 5 mg
Description: PF-3845 is a highly potent and selective inhibitor of fatty acid amide hydrolase (FAAH) with Ki value of 0.23?M [1].PF-3845 is a biaryl ether piperidine.
PF-3845
A4374-5.1
ApexBio 10 mM (in 1mL DMSO)
Description: PF-3845 is a highly potent and selective inhibitor of fatty acid amide hydrolase (FAAH) with Ki value of 0.23?M [1].PF-3845 is a biaryl ether piperidine.
PF-3845
A4374-50
ApexBio 50 mg
Description: PF-3845 is a highly potent and selective inhibitor of fatty acid amide hydrolase (FAAH) with Ki value of 0.23?M [1].PF-3845 is a biaryl ether piperidine.
PF-04620110
A4384-10
ApexBio 10 mg
Description: PF-04620110 is a potent, selective and orally-bioavailable inhibitor of diacylglycerol acyltransferase 1 (DGAT-1), an enzyme catalyzing the final committed step in the biosynthesis of triglycerides, that inhibits DGAT-1 with values of 50% inhibition concentration IC50 of 19 nM and 8 nM in human.
PF-04620110
A4384-5
ApexBio 5 mg
Description: PF-04620110 is a potent, selective and orally-bioavailable inhibitor of diacylglycerol acyltransferase 1 (DGAT-1), an enzyme catalyzing the final committed step in the biosynthesis of triglycerides, that inhibits DGAT-1 with values of 50% inhibition concentration IC50 of 19 nM and 8 nM in human.
PF-04620110
A4384-5.1
ApexBio 10 mM (in 1mL DMSO)
Description: PF-04620110 is a potent, selective and orally-bioavailable inhibitor of diacylglycerol acyltransferase 1 (DGAT-1), an enzyme catalyzing the final committed step in the biosynthesis of triglycerides, that inhibits DGAT-1 with values of 50% inhibition concentration IC50 of 19 nM and 8 nM in human.
PF-04620110
A4384-50
ApexBio 50 mg
Description: PF-04620110 is a potent, selective and orally-bioavailable inhibitor of diacylglycerol acyltransferase 1 (DGAT-1), an enzyme catalyzing the final committed step in the biosynthesis of triglycerides, that inhibits DGAT-1 with values of 50% inhibition concentration IC50 of 19 nM and 8 nM in human.
PF-04691502
A8499-10
ApexBio 10 mg
Description: PF-04691502 is a potent and selective dual PI3K/mTOR (FRAP) inhibitor to phosphorylation of Akt T308 (IC50 = 7.5 nM) and Akt S473 (IC50 = 3.8 nM).
PF-04691502
A8499-5
ApexBio 5 mg
Description: PF-04691502 is a potent and selective dual PI3K/mTOR (FRAP) inhibitor to phosphorylation of Akt T308 (IC50 = 7.5 nM) and Akt S473 (IC50 = 3.8 nM).
PF-04691502
A8499-5.1
ApexBio 10 mM (in 1mL DMSO)
Description: PF-04691502 is a potent and selective dual PI3K/mTOR (FRAP) inhibitor to phosphorylation of Akt T308 (IC50 = 7.5 nM) and Akt S473 (IC50 = 3.8 nM).
PF-04691502
A8499-50
ApexBio 50 mg
Description: PF-04691502 is a potent and selective dual PI3K/mTOR (FRAP) inhibitor to phosphorylation of Akt T308 (IC50 = 7.5 nM) and Akt S473 (IC50 = 3.8 nM).
PF-5274857
A8500-5
ApexBio 5 mg
Description: PF-5274857 is an inhibitor of hedgehog (Hh) signaling pathway and is identified as a potent and selective antagonist of Smoothened (Smo) with an IC50 of 5.8 nM. Smoothened, a G protein-coupled receptor, is a component of the hedgehog signaling pathway and is conserved from flies to humans.
PF-5274857
A8500-5.1
ApexBio 10 mM (in 1mL DMSO)
Description: PF-5274857 is an inhibitor of hedgehog (Hh) signaling pathway and is identified as a potent and selective antagonist of Smoothened (Smo) with an IC50 of 5.8 nM. Smoothened, a G protein-coupled receptor, is a component of the hedgehog signaling pathway and is conserved from flies to humans.
PF-431396
A8692-10
ApexBio 10 mg
Description: PF-431396 is a potent and highly selective pyrimidine-based inhibitor of both Pyk2 and FAK, Consistent with the idea that the tyrosine phosphorylation of Pyk2 and FAK involves an initial autophosphorylation or transphosphorylation step, treating A20 cells.
PF-431396
A8692-200
ApexBio 200 mg
Description: PF-431396 is a potent and highly selective pyrimidine-based inhibitor of both Pyk2 and FAK, Consistent with the idea that the tyrosine phosphorylation of Pyk2 and FAK involves an initial autophosphorylation or transphosphorylation step, treating A20 cells.
PF-431396
A8692-5.1
ApexBio 10 mM (in 1mL DMSO)
Description: PF-431396 is a potent and highly selective pyrimidine-based inhibitor of both Pyk2 and FAK, Consistent with the idea that the tyrosine phosphorylation of Pyk2 and FAK involves an initial autophosphorylation or transphosphorylation step, treating A20 cells.
PF-431396
A8692-50
ApexBio 50 mg
Description: PF-431396 is a potent and highly selective pyrimidine-based inhibitor of both Pyk2 and FAK, Consistent with the idea that the tyrosine phosphorylation of Pyk2 and FAK involves an initial autophosphorylation or transphosphorylation step, treating A20 cells.
PF-04880594
A8811-25
ApexBio 25 mg
Description: PF-04880594 is a selective inhibitor of B-Raf, B-RafV599E and c-Raf with IC50 value of 0.19 nM, 0.13 nM and 0.39 nM, respectively [1].Raf is a serine/threonine protein kinase and plays an important role in the MAPK/ERK signaling pathway.
PF-04880594
A8811-5
ApexBio 5 mg
Description: PF-04880594 is a selective inhibitor of B-Raf, B-RafV599E and c-Raf with IC50 value of 0.19 nM, 0.13 nM and 0.39 nM, respectively [1].Raf is a serine/threonine protein kinase and plays an important role in the MAPK/ERK signaling pathway.
PF-04217903
A5096-100
ApexBio 100 mg
Description: PF-04217903 is an ATP-competitive small-molecule inhibitor of c-Met kinase with Ki value of 4.8 nM [1]. The c-Met kinase is a kind of receptor tyrosine kinases (RTK) and plays critical roles in embryonic development and wound healing.
PF-04217903
A5096-25
ApexBio 25 mg
Description: PF-04217903 is an ATP-competitive small-molecule inhibitor of c-Met kinase with Ki value of 4.8 nM [1]. The c-Met kinase is a kind of receptor tyrosine kinases (RTK) and plays critical roles in embryonic development and wound healing.
PF-04217903
A5096-5
ApexBio 5 mg
Description: PF-04217903 is an ATP-competitive small-molecule inhibitor of c-Met kinase with Ki value of 4.8 nM [1]. The c-Met kinase is a kind of receptor tyrosine kinases (RTK) and plays critical roles in embryonic development and wound healing.
PF-04217903
A5096-5.1
ApexBio 10 mM (in 1mL DMSO)
Description: PF-04217903 is an ATP-competitive small-molecule inhibitor of c-Met kinase with Ki value of 4.8 nM [1]. The c-Met kinase is a kind of receptor tyrosine kinases (RTK) and plays critical roles in embryonic development and wound healing.
PF-562271
A8310-10
ApexBio 10 mg
Description: PF-562271 is a potent, ATP-competitive and reversible inhibitor of both focal adhesion kinase (FAK), a non-receptor tyrosine kinase involved in a variety of cellular events, and proline-rich tyrosine kinase 2 (Pyk2), an FAK homolog containing 48% amino acid identity.
PF-562271
A8310-5
ApexBio 5 mg
Description: PF-562271 is a potent, ATP-competitive and reversible inhibitor of both focal adhesion kinase (FAK), a non-receptor tyrosine kinase involved in a variety of cellular events, and proline-rich tyrosine kinase 2 (Pyk2), an FAK homolog containing 48% amino acid identity.
PF-562271
A8310-5.1
ApexBio 10 mM (in 1mL DMSO)
Description: PF-562271 is a potent, ATP-competitive and reversible inhibitor of both focal adhesion kinase (FAK), a non-receptor tyrosine kinase involved in a variety of cellular events, and proline-rich tyrosine kinase 2 (Pyk2), an FAK homolog containing 48% amino acid identity.
PF-562271
A8310-50
ApexBio 50 mg
Description: PF-562271 is a potent, ATP-competitive and reversible inhibitor of both focal adhesion kinase (FAK), a non-receptor tyrosine kinase involved in a variety of cellular events, and proline-rich tyrosine kinase 2 (Pyk2), an FAK homolog containing 48% amino acid identity.
PF-562271
A8310-S
ApexBio Evaluation Sample
Description: PF-562271 is a potent, ATP-competitive and reversible inhibitor of both focal adhesion kinase (FAK), a non-receptor tyrosine kinase involved in a variety of cellular events, and proline-rich tyrosine kinase 2 (Pyk2), an FAK homolog containing 48% amino acid identity.
PF-00562271
A8320-25
ApexBio 25 mg
Description: PF-562271 is a potent, ATP-competitive and reversible inhibitor of both focal adhesion kinase (FAK), a non-receptor tyrosine kinase involved in a variety of cellular events, and proline-rich tyrosine kinase 2 (Pyk2), an FAK homolog containing 48% amino acid identity.
PF-00562271
A8320-5
ApexBio 5 mg
Description: PF-562271 is a potent, ATP-competitive and reversible inhibitor of both focal adhesion kinase (FAK), a non-receptor tyrosine kinase involved in a variety of cellular events, and proline-rich tyrosine kinase 2 (Pyk2), an FAK homolog containing 48% amino acid identity.
PF-00562271
A8320-5.1
ApexBio 10 mM (in 1mL DMSO)
Description: PF-562271 is a potent, ATP-competitive and reversible inhibitor of both focal adhesion kinase (FAK), a non-receptor tyrosine kinase involved in a variety of cellular events, and proline-rich tyrosine kinase 2 (Pyk2), an FAK homolog containing 48% amino acid identity.
PF-00562271
A8320-S
ApexBio Evaluation Sample
Description: PF-562271 is a potent, ATP-competitive and reversible inhibitor of both focal adhesion kinase (FAK), a non-receptor tyrosine kinase involved in a variety of cellular events, and proline-rich tyrosine kinase 2 (Pyk2), an FAK homolog containing 48% amino acid identity.
PF-03084014
A3711-10
ApexBio 10 mg
Description: PF-03084014 is a reversible and selective inhibitor of ?-secretase with IC50 value of 6.2 nM [1].The Notch signaling pathway is triggered by the interaction of Notch ligand and Notch receptor located in the membrane of the adjacent cell.
PF-03084014
A3711-100
ApexBio 100 mg
Description: PF-03084014 is a reversible and selective inhibitor of ?-secretase with IC50 value of 6.2 nM [1].The Notch signaling pathway is triggered by the interaction of Notch ligand and Notch receptor located in the membrane of the adjacent cell.
PF-03084014
A3711-5
ApexBio 5 mg
Description: PF-03084014 is a reversible and selective inhibitor of ?-secretase with IC50 value of 6.2 nM [1].The Notch signaling pathway is triggered by the interaction of Notch ligand and Notch receptor located in the membrane of the adjacent cell.
PF-03084014
A3711-50
ApexBio 50 mg
Description: PF-03084014 is a reversible and selective inhibitor of ?-secretase with IC50 value of 6.2 nM [1].The Notch signaling pathway is triggered by the interaction of Notch ligand and Notch receptor located in the membrane of the adjacent cell.
PF-04447943
A3713-10
ApexBio 10 mg
Description: PF-04447943 is a potent and selective inhibitor of PDE9 [1]. Phosphodiesterase 9 (PDE9) selectively degrades cGMP and limits the cGMP-mediated signal transduction which occurs following glutamate binding to NMDA receptors.
PF-04447943
A3713-25
ApexBio 25 mg
Description: PF-04447943 is a potent and selective inhibitor of PDE9 [1]. Phosphodiesterase 9 (PDE9) selectively degrades cGMP and limits the cGMP-mediated signal transduction which occurs following glutamate binding to NMDA receptors.
PF-04447943
A3713-5
ApexBio 5 mg
Description: PF-04447943 is a potent and selective inhibitor of PDE9 [1]. Phosphodiesterase 9 (PDE9) selectively degrades cGMP and limits the cGMP-mediated signal transduction which occurs following glutamate binding to NMDA receptors.
PF-04971729
A3715-10
ApexBio 10 mg
Description: PF-04971729, a potent and selective inhibitor of the sodium-dependent glucose cotransporter 2, is currently in phase 2 trials for the treatment of diabetes mellitus. Inhibitory effects against the organic cation transporter 2-mediated uptake of [14C]metformin by PF-04971729 also were very weak.
PF-04971729
A3715-25
ApexBio 25 mg
Description: PF-04971729, a potent and selective inhibitor of the sodium-dependent glucose cotransporter 2, is currently in phase 2 trials for the treatment of diabetes mellitus. Inhibitory effects against the organic cation transporter 2-mediated uptake of [14C]metformin by PF-04971729 also were very weak.
PF-04971729
A3715-5
ApexBio 5 mg
Description: PF-04971729, a potent and selective inhibitor of the sodium-dependent glucose cotransporter 2, is currently in phase 2 trials for the treatment of diabetes mellitus. Inhibitory effects against the organic cation transporter 2-mediated uptake of [14C]metformin by PF-04971729 also were very weak.
PF-3758309
A3716-10
ApexBio 10 mg
Description: PF-3758309 is an inhbitor of PAK4 with IC50 of 1.3 nM [1].P21-activated kinases (PAKs) are the family of serine/theronine kinases, which play important role in linking Rho GTPase to cytoskeleton reorganization and nuclear signaling.

Did not find what you were looking for? Send us request and we will contact with you!